পৃষ্ঠা 1 থেকে 18 ফলাফল
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R)-zeaxanthin and (3R,3'S;meso)-zeaxanthin from a dehydration product of (3R,3'R,6'R)-lutein, namely,
BACKGROUND OF THE INVENTION
This invention is in the field of pharmacology, and relates to human use of a yellow pigment called zeaxanthin (ZX) in preventing or treating macular degeneration, a disease which damages retinal tissue and causes blindness.
This application is being simultaneously filed
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue
BACKGROUND OF THE INVENTION
This invention is in the field of biochemistry, pharmacology, and nutritional supplements, and relates to a new use for zeaxanthin, a carotenoid found in plants such as spinach, kale, and corn.
Numerous efforts have been made to identify drugs or other biomolecules that
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national phase application of the PCT international application number PCT/CN2013/000933 titled "Composition Used For Improving Macular Pigment Density In Eyes And Preventing Or Treating Age-related Macular Degeneration", filed in the
BACKGROUND OF THE INVENTION
This invention is in the field of pharmacology, and relates to human use of a yellow pigment called zeaxanthin (ZX) in preventing or treating macular degeneration, a disease which damages retinal tissue and causes blindness.
A related U.S. Pat. No. 5,854,015 ("Method of
FIELD OF THE INVENTION
This invention is in the fields of biochemistry, pharmacology, and nutritional supplements, and relates to orally-ingested formulations for treating or preventing eye diseases and vision problems.
BACKGROUND OF THE INVENTION
Hundreds of different dietary supplements, under
FIELD OF THE INVENTION
This invention is in the fields of biochemistry, pharmacology, and nutritional supplements, and relates to orally-ingested formulations for treating or preventing eye diseases and vision problems.
BACKGROUND OF THE INVENTION
Hundreds of different dietary supplements, under
FIELD OF THE INVENTION
This invention is in the fields of biochemistry, pharmacology, and nutritional supplements, and relates to orally-ingested formulations for treating or preventing eye diseases and vision problems.
BACKGROUND OF THE INVENTION
Hundreds of different dietary supplements, under
FIELD OF THE INVENTION
This invention is in the fields of biochemistry, pharmacology, and nutritional supplements, and relates to orally-ingested formulations for treating or preventing eye diseases and vision problems.
BACKGROUND OF THE INVENTION
Hundreds of different dietary supplements, under
The invention related to the use of lutein and zeaxanthin which increase the deposition of macular pigment in the human eye. The invention is particularly but not exclusively concerned with lutein and/or zeaxanthin for use in the treatment by therapy or prophylaxis of disease of the macula and in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R,6'R)-lutein and its stereoisomers from commercially available (rac)-.alpha.-ionone by a C.sub.15+C.sub.10+C.sub.15 coupling
FIELD OF THE INVENTION
The invention relates to the determination of the freshness of agricultural crops, products, and forests, and in particular, to the determination of antioxidant content through optical methods.
BACKGROUND OF THE INVENTION
In plants, carotenoids act as accessory pigments in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to the use of meso-zeaxanthin to increase the deposition of macular pigment in the human eye, and for the therapeutic treatment or prophylaxis of diseases and disorders of the macula, and in particular age-related macular